Ligand validation:6EV6

FZZ: 1-deoxy-5-O-phosphono-1-[(10aR)-2,2,3,4-tetramethyl-8,10-dioxo-1,2,8,9,10,10a-hexahydro-6H-indeno[1,7-ef]pyrimido[4,5-b][1,4]diazepin-6-yl]-D-ribitol

FZZ is a Ligand Of Interest in 6EV6 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6EV6_FZZ_A_604	81%	3%	0.122	0.975	2.45	3.41	11	14	4	0	100%	0.5
4ZA7_FZZ_A_602	97%	18%	0.076	0.99	2.23	1.3	9	4	4	0	100%	0.5
4ZA5_FZZ_A_602	95%	6%	0.084	0.989	2.37	2.76	9	16	12	0	100%	0.5
4ZA8_FZZ_A_602	94%	8%	0.084	0.983	3.18	1.49	15	5	3	0	100%	0.5
4ZAA_FZZ_A_602	93%	8%	0.081	0.974	2.95	1.8	9	10	5	0	100%	0.5
4ZAB_FZZ_A_602	89%	13%	0.101	0.982	2.79	1.21	12	3	1	0	100%	0.5
6EV3_FZZ_A_605	89%	5%	0.092	0.971	2.41	2.88	9	14	4	0	100%	0.5

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.